The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors.
Otava T, Šála M, Li F, Fanfrlík J, Devkota K, Perveen S, Chau I, Pakarian P, Hobza P, Vedadi M, Boura E, Nencka R.
Otava T, et al. Among authors: pakarian p.
ACS Infect Dis. 2021 Aug 13;7(8):2214-2220. doi: 10.1021/acsinfecdis.1c00131. Epub 2021 Jun 21.
ACS Infect Dis. 2021.
PMID: 34152728